Immunotherapy Outcomes in Advanced Melanoma in Relation to Age

INTRODUCTION: Older age is a melanoma risk factor. Elderly individuals are likelier to have immunosenescence, which could help melanoma cells escape immune surveillance. Hence, it is believed that elderly people cannot mount a potent immune response to checkpoint inhibitors to eliminate melanoma. OB...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Perm J
Autores principales: Joshi, Krishna, Atwal, Dinesh, Ravilla, Rahul, Pandey, Yadav, Yarlagadda, Naveen, Kakadia, Sunil, Makhoul, Issam, Hutchins, Laura, Mahmoud, Fade
Formato: Artigo
Lenguaje:Inglês
Publicado: The Permanente Journal 2020
Materias:
Original Research & Contributions
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039418/
https://ncbi.nlm.nih.gov/pubmed/32097116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/19.093
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares